The impact of perceived interpersonal functioning on treatment for adolescent depression: IPT-A versus treatment as usual in school-based health clinics.

Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, NY 10032, USA.
Journal of Consulting and Clinical Psychology (Impact Factor: 4.85). 04/2010; 78(2):260-7. DOI: 10.1037/a0018935
Source: PubMed

ABSTRACT Aspects of depressed adolescents' perceived interpersonal functioning were examined as moderators of response to treatment among adolescents treated with interpersonal psychotherapy for depressed adolescents (IPT-A; Mufson, Dorta, Moreau, & Weissman, 2004) or treatment as usual (TAU) in school-based health clinics.
Sixty-three adolescents (12-18 years of age) participated in a clinical trial examining the effectiveness of IPT-A (Mufson, Dorta, Wickramaratne, et al., 2004). The sample was 84.1% female and 15.9% male (mean age = 14.67 years). Adolescents were 74.6% Latino, 14.3% African American, 1.6% Asian American, and 9.5% other. They came primarily from low-income families. Adolescents were randomly assigned to receive IPT-A or TAU delivered by school-based mental health clinicians. Assessments, completed at baseline and at Weeks 4, 8, and 12 (or at early termination), included the Hamilton Rating Scale for Depression (Hamilton, 1967), the Conflict Behavior Questionnaire (Robin & Foster, 1989), and the Social Adjustment Scale-Self-Report (Weissman & Bothwell, 1976).
Multilevel modeling indicated that treatment condition interacted with adolescents' baseline reports of conflict with their mothers and social dysfunction with friends to predict the trajectory of adolescents' depressive symptoms over the course of treatment, controlling for baseline levels of depression. The benefits of IPT-A over TAU were particularly strong for the adolescents who reported high levels of conflict with their mothers and social dysfunction with friends.
Replication with larger samples would suggest that IPT-A may be particularly helpful for depressed adolescents who are reporting high levels of conflict with their mothers or interpersonal difficulties with friends.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Major Depressive Disorder (MDD) in children and adolescents is a common and impairing condition that is both recurrent and persistent into adulthood. In this article, a review of the literature regarding multimodal treatment is presented. The literature review process for this article included «adolescents», «children», «depression», «treatment», «antidepressants» and «psychotherapy» as key words. The initial Medline search covered a 10 year period dating back to 2001. Double blind randomized and meta-analysis studies were considered as gold standard to be included in the revision, but also experts' consensus were incorporated. Regarding pharmacological treatment, tricyclic-antidepressants did not show better efficacy against placebo in double blind controlled studies; selective serotonin reuptake inhibitors showed better efficacy against placebo in controlled studies, specifically fluoxetine and escitalopram, both approved to be used in pediatric population with MDD. Noradrenalin and serotonin reuptake inhibitors like venlafaxine or mirtazapine had not shown superior response than placebo. Comorbidity needs to be taken into account in the decisions of the pharmacological treatment; attention deficit hyperactivity disorder is the most frequent associated disorder and requires to add specific drug treatment like stimulants; if psychotic symptoms are present, atypical antipsychotics should be added. Regarding psychosocial treatment, psychoeducation is the first step in this treatment approach. Psychotherapy aims include decreasing symptoms severity by improving self esteem, increasing frustration tolerance and autonomy, as well as the ability to enjoy daily life activities, and establishing good relations with peers. Interpersonal and cognitive behavioral therapies are good options as psychotherapy for this age group. It is important to monitor patients to prevent relapses and complications of depression and suicidal behavior.
    Salud Mental 10/2011; 34(5):403-407. · 0.42 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Genetic moderation of interpersonal psychotherapy (IPT) efficacy for economically disadvantaged women with major depressive disorder was examined. Specifically, we investigated whether genotypic variation in corticotropin releasing hormone receptor 1 (CRHR1) and the linked polymorphic region of the serotonin transporter gene (5-HTTLPR) moderated effects of IPT on depressive symptoms over time. We also tested genotype moderation of IPT mechanisms on social adjustment and perceived stress. Non-treatment-seeking urban women at or below the poverty level with infants were recruited from the community (N = 126; M age = 25.33 years, SD = 4.99; 54.0% African American, 22.2% Caucasian, and 23.8% Hispanic/biracial) and randomized to individual IPT or Enhanced Community Standard groups. The results revealed that changes in depressive symptoms over time depended on both intervention group and genotypes (5-HTTLPR and CRHR1). Moreover, multiple-group path analysis indicated that IPT improved depressive symptoms, increased social adjustment, and decreased perceived stress at posttreatment among women with the 0 copies of the CRHR1 TAT haplotype only. Finally, improved social adjustment at postintervention significantly mediated the effect of IPT on reduced depressive symptoms at 8 months postintervention for women with 0 copies of the TAT haplotype only. Post hoc analyses of 5-HTTLPR were indicative of differential susceptibility, albeit among African American women only.
    Development and Psychopathology 02/2015; 27(1):19-35. DOI:10.1017/S0954579414001278 · 4.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Mental health problems of children are commonly treated by psychotherapy and other psychosocial treatments. Studies comparing different treatments in naturalistic clinical settings are few, however. Aims: We assessed the differences: 1) in symptoms and diagnoses; 2) in treatment outcome between psychotherapy and other psychosocial treatments; and 3) evaluated the effect of family background and life circumstances on the outcome. Methods: The data were collected from the psychiatric hospital records of Oulu University Hospital, Finland. All 118 children (aged < 16 years) referred to psychotherapy from the Department of Child Psychiatry in 1996-2005 and 118 age- and sex-matched children undergoing other psychosocial treatments were included. A lack of later recorded psychiatric problems was used as an indicator of good treatment outcome. Results: On referral, functional ability was severely impaired in almost half of the children (Children's Global Assessment Scale score < 55). Internalizing symptoms were more common in the psychotherapy group, while no difference was found in externalizing symptoms between the groups. In both groups, later psychiatric problems were associated with a child's low functional ability and poor parental coping with their responsibilities. Children with internalizing problems had impaired prognosis if they had psychosocial treatments other than psychotherapy. Conclusions: Individual psychotherapy should especially be considered for children with internalizing symptoms, but the outcome of psychiatric treatment depends not only on children's own functional abilities, but also on parental abilities.
    Nordic Journal of Psychiatry 09/2014; 69(3):1-9. DOI:10.3109/08039488.2014.954268 · 1.50 Impact Factor

Full-text (2 Sources)

Available from
May 22, 2014